Wildy logo
(020) 7242 5778
enquiries@wildy.com

Wildy’s Book News

Book News cover photo

Vol 21 No 10 Oct/Nov 2016

Book of the Month

Cover of Criminal Injuries Compensation Claims

Criminal Injuries Compensation Claims

Price: £99.95

Pupillage & Student Offers

Special Discounts for Pupils, Newly Called & Students

Read More ...


Secondhand & Out of Print

Browse Secondhand Online

Read More...


Regulating Human Embryonic Stem Cell in China: A Comparative Study on Human Embryonic Stem Cell's Patentability and Morality in US and EU


ISBN13: 9789811021008
Published: August 2016
Publisher: Springer-Verlag
Country of Publication: Singapore
Format: Hardback
Price: £104.50



This is a Print On Demand Title.
The publisher will print a copy to fulfill your order. Books can take between 1 to 3 weeks. Looseleaf titles between 1 to 2 weeks.

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China. The book highlights that both patent control and federal funding control are inefficient and ineffective way to monitoring human embryonic stem cell research.

The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. The topic discussed will also be interesting to a broad readership, including experts, regulators, policy makers and medical researchers in both ethical and legal disciplines in the field of embryonic stem cell research.

Subjects:
Intellectual Property Law, Medical Law, Other Jurisdictions , China
Contents:
Values of Human Embryonic Stem Cell Research, the phenomenon of "Stem Cell Tourism" and Inadequate regulation of Human Embryonic Stem Cell in China
The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell
China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application
The United States: Inconsistent policies on federal funding control of human embryonic stem cell research
The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research
A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.